We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Product News

NextGen Sciences Launches Multiple Protein Plasma Oncology Biomarker Assay

NextGen Sciences Inc. has launched its first multiple protein (multiplex) assay, plasmadiscovery41, for oncology biomarker discovery and qualification. The assay simultaneously measures 41 human plasma proteins that are thought to have potential as biomarkers in cancer, particularly breast, prostate and lung cancers.
Product News

Sigma® Life Science adds 1,400 Cell Lines to its U.S. Portfolio of ECACC® Products

Sigma Life Science has announced the addition of 1,400 new European Collection of Cell Culture (ECACC) cell lines to its collection of cell line cultures and services.
Product News

Lpath Granted Another Key U.S. Patent Related to iSONEP and ASONEP Drug Programs

New U.S. patent adds to four others received over last six months.
Product News

Peregrine Announces Initiation of Lung Cancer Investigator-Sponsored Trial

Targeted antibody bavituximab to be evaluated in combination with pemetrexed and carboplatin for front-line non-small cell lung cancer.
Product News

Radient Pharmaceuticals Confirms Study for its Onko-Sure® In Vitro Diagnostic Cancer Test

The project is designed to further validate the efficiency of Onko-Sure® relative to the CEA marker in colorectal cancer patients.
Product News

Medivation and Astellas Announce Data From Phase 1-2 Trial of MDV3100 in Advanced Prostate Cancer Patients

MDV3100 continues to show durable antitumor activity as evaluated by median times to prostate-specific antigen progression and radiographic progression.
Product News

Marina Biotech Publishes Pre-Clinical Research on RNAi-Based Therapeutics Targeting Survivin and PLK1 in Bladder Cancer

Research published in molecular therapy shows gene specific silencing resulted in up to a 60-fold decrease in tumor volume.
Product News

Precision Therapeutics and Med BioGene Partner to Commercialize LungExpress Dx™

LungExpress Dx™ is a proprietary gene expression-based test to improve upon staging for identifying those patients with early-stage NSCLC.
Product News

Celsion Announces ThermoDox® Preclinical Data Publication and Presentations at Upcoming Scientific Conferences

Data support clinical studies in bone cancer planned for 2011.
Product News

Poniard Pharmaceuticals Receives Chinese State FDA Approval for Clinical Development of Picoplatin

Company receives CTA approval to conduct two Phase III clinical studies of picoplatin, in the treatment of second-line SCLC and second-line ovarian cancer in the People's Republic of China.
Advertisement